Sangamo Therapeutics, Inc. · NASDAQ:SGMO
Dubois-Stringfellow Nathalie sold 345,942 Sangamo Therapeutics, Inc. shares (Form 4)
Traded Apr 21, 2026 · Filed Apr 23, 2026
On Apr 21, 2026, Dubois-Stringfellow Nathalie (SVP-CHIEF DEVELOPMENT OFFICER) sold 345,942 Sangamo Therapeutics, Inc. shares at US$0.26 for US$89,945, leaving 332,769 shares. Filed Apr 23, 2026 (Form 4).
- Sold
- 345,942 shares
- Price
- US$0.26
- Value
- US$89,945
- Holding after
- 332,769 shares
- Trading plan
- No
- Role
- SVP-CHIEF DEVELOPMENT OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 21, 2026 | Common Stock | Sale | 345,942 | US$0.26 | 332,769 | Direct |
Source
Related
- Sangamo Therapeutics, Inc.
- Dubois-Stringfellow Nathalie
- Sangamo Therapeutics, Inc. shareholders
- Form 4 · Dubois-Stringfellow Nathalie · May 27, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · Davis Gregory D · May 27, 2026
- Form 4 · Jain Nikunj · May 27, 2026
- Form 4 · Willoughby Scott B. · May 27, 2026
- Form 4 · Macrae Sandy · May 27, 2026